CCI approves proposed transaction involving sale of global biosimilars portfolio of Viatris Inc. to Biocon Biologics Limited and an equity infusion in Biocon Biologics by Biocon and Serum https://www.taxtmi.com/news?id=25506 The Competition Commission of India approved a cross-border combination where Viatris will sell its global biosimilars portfolio to Biocon Biologics for cash and stock, and Mylan will take equity and convertible preference shares in Biocon Biologics as part consideration, modifying the target's ownership structure; detailed regulatory order to follow. en-us Tue, 14 Jun 2022 18:18:41 +0530 Tue, 14 Jun 2022 18:18:41 +0530 TaxTMI RSS Generator CCI approves proposed transaction involving sale of global biosimilars portfolio of Viatris Inc. to Biocon Biologics Limited and an equity infusion in Biocon Biologics by Biocon and Serum https://www.taxtmi.com/news?id=25506 The Competition Commission of India approved a cross-border combination where Viatris will sell its global biosimilars portfolio to Biocon Biologics for cash and stock, and Mylan will take equity and convertible preference shares in Biocon Biologics as part consideration, modifying the target's ownership structure; detailed regulatory order to follow. News - Tue, 14 Jun 2022 18:18:41 +0530 https://www.taxtmi.com/news?id=25506